NAALADL2-DRD3 Fusion FISH Probe
The NAALADL2-DRD3 Fusion FISH Probe is used to confirm a fusion of the NAALADL2 and DRD3 genes. The fusion of the NAALADL2 and DRD3 genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NAALADL2-DRD3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NAALADL2-DRD3-20-AQAQ | 20 (40 μL) | 200 μL |
|
DRD3 Gene Summary
This gene encodes the D3 subtype of the five (D1-D5) dopamine receptors. The activity of the D3 subtype receptor is mediated by G proteins which inhibit adenylyl cyclase. This receptor is localized to the limbic areas of the brain, which are associated with cognitive, emotional, and endocrine functions. Genetic variation in this gene may be associated with susceptibility to hereditary essential tremor 1. Alternative splicing of this gene results in transcript variants encoding different isoforms, although some variants may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Jul 2008]
Gene Name: Dopamine Receptor D3
Chromosome: CHR3: 113847556 -113897899
Locus: 3q13.31
NAALADL2 Gene Summary
The N-acetylated Alpha-linked Acidic Dipeptidase Like 2 (NAALADL2) gene is located on chr3 :174577110-175523428 at 3q26.31.
Gene Name: N-acetylated Alpha-linked Acidic Dipeptidase Like 2
Chromosome: CHR3: 174577110 -175523428
Locus: 3q26.31
Gene Diseases
The NAALADL2 DRD3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Head And Neck Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|